Hansa Biopharma AB (publ) (OTCMKTS:HNSBF) Shares Up 24.6% – Here’s Why

Hansa Biopharma AB (publ) (OTCMKTS:HNSBF) shot up 24.6% during mid-day trading on Tuesday . The stock traded as high as $3.65 and last traded at $3.65. 200 shares were traded during trading, a decline of 53% from the average session volume of 425 shares. The stock had previously closed at $2.93.

Hansa Biopharma AB (publ) Stock Performance

The business has a 50 day moving average price of $2.94 and a 200-day moving average price of $2.94.

Hansa Biopharma AB (publ) Company Profile

Hansa Biopharma AB (publ), a biopharmaceutical company, engages in development and commercialization of treatments for patients with rare immunological conditions in Europe and the United States. The company offers Idefirix(imlifidase), which targets and cleaves all classes of immunoglobulin G (IgG) antibodies for the desensitization treatment of sensitized adult kidney transplant patients with a positive crossmatch test.